Clinical Trial Update: Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). [Phase 3]

View source ↗

Summary

This clinical trial update indicates a Phase 3 study evaluating Realgar-Indigo Naturalis Formula (RIF) combined with all-trans retinoic acid (ATRA) for treating…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Realgar-Indigo Naturalis Formula (realgar-indigo naturalis formula)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: APL | Phase 3 | Status: RECRUITING